AppliedVR, a Los Angeles, CA-based company advancing immersive therapeutics, raised $36m in Series B funding, bringing its total funding to $71m.
The round included investments from F-Prime Capital, JAZZ Venture Partners, Sway Ventures and SVB Ventures.
The company intends to use the funds to continue to prepare for EaseVRx’s full market launch after FDA approval, finish additional payer pilots, build out its product pipeline, conduct more clinical research, and continue building its VR pharmacy platform.
Co-founded in 2015 by Matthew Stoudt and Josh Sackman, AppliedVR is an immersive therapeutics company advancing virtual reality-based treatments that address the complexity of pain and other conditions. The company’s flagship immersive therapeutic device for chronic pain has received FDA Breakthrough Device Designation to enable patients to change the way they process pain and develop new, positive habits and coping skills that improve quality of life.
AppliedVR is already used by more than 200 of the world’s leading health systems and the technology has been used by more than 60,000 patients to date in pain management and wellness programs.
FinSMEs
11/11/2021